* STB-C017 is an IDO/TDO dual inhibitor, derived from Syntekabio's proprietary drug discovery arti...
DAEJEON, South Korea, May 15, 2020 /PRNewswire/ -- Syntekabio (KOSDAQ: 226330), an AI and NGS based...
